Markets:

Overview

News

Currencies

International

Treasuries

Neuronetics, Inc. - Common Stock (NQ:STIM)

1.340 +0.040 (+3.08%)

Streaming Delayed Price Updated: 3:15 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Neuronetics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Short Volatility Alert: Neuronetics, Inc. ↗

September 23, 2022

On Thursday, shares of Neuronetics, Inc. (NASDAQ: STIM) experienced volatile short activity. After the activity, the stock price went up +0.76% to $2.65. The overall sentiment for STIM has been...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 30, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 19, 2022

Gainers

Via Benzinga

Despite Competition This Analyst Finds BrainsWay Attractive ↗

August 11, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 09, 2022

Via Benzinga

Recap: Neuronetics Q2 Earnings ↗

August 02, 2022

Neuronetics (NASDAQ:STIM) reported its Q2 earnings results on Tuesday, August 2, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Read Why Neuronetics Shares Are Trading Higher Today ↗

July 19, 2022

Via Benzinga

Recap: Neuronetics Q1 Earnings ↗

May 12, 2022

Neuronetics (NASDAQ:STIM) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For August 2, 2022 ↗

August 02, 2022

Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 26, 2022

During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.

Via Benzinga

Neuronetics's Earnings: A Preview ↗

August 01, 2022

Neuronetics (NASDAQ:STIM) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Neuronetics will...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 20, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

July 20, 2022

Investors ready to start trading early this morning will want to check out the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

Recap of Tuesday's Biotech Catalysts - End Of The Day Summary ↗

July 19, 2022

The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness...

Via Benzinga

Recap: Neuronetics Q4 Earnings ↗

March 08, 2022

Neuronetics (NASDAQ:STIM) reported its Q4 earnings results on Tuesday, March 8, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

NCR Stock Pops 13% on Buyout News ↗

July 19, 2022

NCR (NCR) stock is rising higher on Tuesday following reports that private-equity firm Veritas wants to buy the company and take it private.

Via InvestorPlace

Why Is Neuronetics (STIM) Stock Up 12% Today? ↗

July 19, 2022

Neuronetics (STIM) stock is taking off on Tuesday after the announcing approval from the FDA for a new use of a metal health treatment.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 19, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 10, 2022

Gainers Avalon Globocare (NASDAQ:AVCO) stock rose 14.8% to $0.54 during Tuesday's after-market session. The market value of their outstanding shares is at $47.8 million.

Via Benzinga

Neuronetics Earnings Conference Call Is Coming Up, Here's What You Need To Know ↗

April 29, 2022

Neuronetics (NASDAQ:STIM) will host a conference call at 08:30 AM ET on May 12, 2022, to discuss Q1 2022 earnings results. How to Attend Neuronetics (STIM) Conference Call Follow this link to access...

Via Benzinga

Earnings Scheduled For May 12, 2022 ↗

May 12, 2022

Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.

Via Benzinga

99 Biggest Movers From Yesterday ↗

May 12, 2022

Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company.

Via Benzinga

52 Stocks Moving In Wednesday's Mid-Day Session ↗

May 11, 2022

Gainers Trecora Resources (NYSE: TREC) shares jumped 26.6% to $9.56 as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247...

Via Benzinga

Executives Buy Around $1M Of 4 Penny Stocks ↗

April 05, 2022

The ISM services PMI rose to 58.3 in March from 56.5 in the previous month. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Insiders Buying These 4 Penny Stocks ↗

March 30, 2022

The Nasdaq Composite gained around 60 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

Neuronetics's Return On Capital Employed Insights ↗

March 10, 2022

According to data from Benzinga Pro, during Q4, Neuronetics's (NASDAQ:STIM) reported sales totaled $15.02 million. Despite a 6.32% increase in earnings, the company posted a loss...

Via Benzinga

Neuronetics Posts Better Than Expected Q4 Results Despite Lower NeuroStar Therapy System Sales ↗

March 08, 2022

Neuronetics Inc (NASDAQ: STIM) reported Q4 FY21 sales of $15.02 million, down 4% Y/Y, exceeding previously issued guidance of $13.0 million - $14.0 million and the...

Via Benzinga

The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout ↗

March 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative...

Via Benzinga

Preview: Neuronetics's Earnings ↗

March 07, 2022

Neuronetics (NASDAQ:STIM) is set to give its latest quarterly earnings report on Tuesday, 2022-03-08. Here's what investors need to know before the announcement. Analysts estimate...

Via Benzinga

Earnings Scheduled For March 8, 2022 ↗

March 08, 2022

Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Neuronetics, Inc. - Common Stock (NQ:STIM)

All News about Neuronetics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today